高级搜索
吡喃阿霉素为主方案治疗难治和复发性急性白血病[J]. 肿瘤防治研究, 1998, 25(1): 55-57.
引用本文: 吡喃阿霉素为主方案治疗难治和复发性急性白血病[J]. 肿瘤防治研究, 1998, 25(1): 55-57.
Treatment of relapsed and refractory acute leukemia with regimens THP et al[J]. Cancer Research on Prevention and Treatment, 1998, 25(1): 55-57.
Citation: Treatment of relapsed and refractory acute leukemia with regimens THP et al[J]. Cancer Research on Prevention and Treatment, 1998, 25(1): 55-57.

吡喃阿霉素为主方案治疗难治和复发性急性白血病

Treatment of relapsed and refractory acute leukemia with regimens THP et al

  • 摘要: 目的:探讨吡喃阿霉素为主方案治疗难治和复发性急性白血病的疗效。 方法:TA、THA和TOAP方案。 结果:8例病人中5例达完全缓解,且例部分缓解。 结论:吡喃阿霉素为主方案治疗难治和复发性急性白血病有一定疗效, 其副作用可以耐受。

     

    Abstract: To evaluate the effect of THP in relapsed and refractory acute leukemia, eight patients with relapsed and refractory acute leukemia were treated with THP+Ara-C orTHP+VCR+Ara-C+Pred and THP+Har+Ara-C. Of the 8 patients, 5 patientsachieved complete remission(CR) and 1 patient partial remission(PR). In conclusion,the combination of THP with Ara-c et al is effective in the treatment of relapsed and refractory acute leukemia and the toxicities were tolerated.

     

/

返回文章
返回